Effect of MD1003 in Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis

NCT02220244 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: MD1003 100mg capsule

Sponsor

MedDay Pharmaceuticals SA